Ligand Pharmaceuticals
LGND
#2784
Rank
$6.03 B
Marketcap
$302.96
Share price
0.07%
Change (1 day)
68.20%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $1.21 Billion USD

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are $1.21 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.54 B388.1%
2024-12-31$0.11 B29%
2023-12-31$86.3 M-47.75%
2022-12-31$0.16 B-65.33%
2021-12-31$0.47 B-27.01%
2020-12-31$0.65 B-10.3%
2019-12-31$0.72 B3.97%
2018-12-31$0.69 B177.32%
2017-12-31$0.25 B9.38%
2016-12-31$0.23 B2.03%
2015-12-31$0.22 B-3.2%
2014-12-31$0.23 B323.99%
2013-12-31$55.1 M-29.15%
2012-12-31$77.77 M-30.8%
2011-12-31$0.11 B39.78%
2010-12-31$80.4 M-41.76%
2009-12-31$0.13 B-24.06%
2008-12-31$0.18 B26.12%
2007-12-31$0.14 B-51.74%
2006-12-31$0.29 B-29.72%
2005-12-31$0.42 B4.23%
2004-12-31$0.40 B15.98%
2003-12-31$0.35 B74.57%
2002-12-31$0.20 B14.87%
2001-12-31$0.17 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$116.09 B 9,428.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 9,391.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$108.40 B 8,797.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.95 B 6,790.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$13.61 B 1,017.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$87.81 B 7,107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$65.31 B 5,260.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$59.04 B 4,746.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
$80.87 M-93.36%๐Ÿ‡บ๐Ÿ‡ธ USA